Senior insider sale
Chief Scientific Officer at ARBUTUS BIOPHARMA CORP — senior position signals high conviction
$852.9K
267.16K shares
What this filing means
SOFIA MICHAEL J. plans to sell 267.16K shares of ARBUTUS BIOPHARMA CORP valued at approximately $852.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/13/2025ACC: 0001959173-25-002014
Officer· Chief Scientific Officer
Since Jul 2018
267.16K
Shares to sell
$852.9K
Approx. market value
100K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Merger Acquisition
Cash/Check
9/26/2012
100KTotal acquired100K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/26/2012 | Merger Acquisition Cash/Check | 100K | — |
| Total | 100K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
157.16K
Market value
$481.3K
3/11/2025
—Completed
Units to sell
10K
Market value
$33.6K
3/7/2025
Planned — Approximate Date
nasdaqPlanned
Units to sell
100K
Market value
$338.0K
3/13/2025
Total
Units
267.16K
Value
$852.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/11/2025 | 157.16K | $481.3K | — | Completed |
3/7/2025 | 10K | $33.6K | — | Completed |
| Planned — Approximate Date | ||||
3/13/2025 | 100K | $338.0K | nasdaq | Planned |
| Total | 267.16K | $852.9K | ||